Considering the phenotypic overlap of all four patients, we postulate that patients with homozygous or compound heterozygous YRDC mutations should be viewed as a distinct entity based on the specific phenotypic features of congenital hypothyroidism, progeroid appearance and premature death. The gene discussed is YRDC; the disease is congenital hypothyroidism.